11:00 – 11:10

Welcome Address

Eileen Regan

VP, Life Science Applications, Global 

Indica Labs 

11:10 – 11:40

New Features and Upcoming Developments in Life Science Products at Indica Labs 

Noemi Kedei, MD

Director of Product, Life Sciences

Indica Labs

Biography

Noemi Kedei earned an MD degree from University Medical School of Debrecen, Hungary. She did her postdoctoral training and worked later as staff scientist in the Laboratory of Cancer Biology and Genetics, NCI. Her research focused on identifying mechanisms involved in the differential effect of natural compounds and their engineered derivatives acting on protein kinase Cs (PKCs), validated targets for anti-cancer treatment. In 2018 she joined the Collaborative Protein Technology Resources (OSTR, CCR, NCI) core facility to implement a variety of spatial protein and transcriptomics technologies and lead related operations provided as services to NCI investigators. Noemi provided the expertise for development of project based customized antibody protein panels for detection of 40-60 protein targets at single cell level in tissue sections using the CODEX/Phenocycler fusion technology, and ensured optimal end efficient instrument use. In addition, she advised and supported users on image analysis tools for quantitative image analysis combining different AI-enabled HALO modules and NCI developed pipelines for downstream analysis. Noemi joined Indica Labs as Director of Product - Life Sciences in May, 2025.

11:40 - 12:10

Analytical Workflow Selection in HALO: Beyond Standard Pipelines 

Cara Brodie, BSc, MSc

Senior Scientific Associate

Cancer Research UK Cambridge Institute

Biography

Cara has a BSc Biomedical Science from University of Central Lancashire and a MSc in Biomedical Science from University of Greenwich. Cara is a Senior Scientific Associate in image analysis offering brightfield and fluorescent image analysis solutions in the Histopathology/ISH Core Facility.

12:10 - 12:30

Application of the ADC Target Module for Quantitative Continuous Scoring 

Pedro Espinosa Gonzalez

Senior Field Applications Scientist - EMEA

Indica Labs

Biography

Pedro brings 13 years of expertise as a Histology technician, having worked in both hospital and research laboratory settings prior to joining Indica Labs in 2022. In his current role as Senior Field Applications Scientist, Pedro is responsible for training and supporting customers, leveraging his extensive practical knowledge to assist users of Indica Labs’ products.

Pedro has developed a specialization in various staining techniques, including those used for routine diagnostics and advanced research such as In Situ Hybridization (ISH), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Immunofluorescence (IF), and multiple histochemical methods. Additionally, he possesses significant experience in operating confocal and super resolution microscopes, as well as analyzing the complex images produced by these advanced imaging technologies.

12:30 - 13:30

Lunch

13:30 - 14:00

Toward a Fully Digitalized Image Analysis 

Alice Lallo, PhD

Principal Scientist 1

Novartis Pharma G

Biography

Alice was born in Turin, Italy, and is specialized in cancer research with a strong focus on translational applications. She completed her PhD at Cancer Research UK in Manchester, UK, in the laboratory of Professor Caroline Dive, where she explored biomarkers of drug resistance and drug response.

Following her PhD, Alice moved to Basel, Switzerland, to pursue a postdoctoral fellowship at Novartis. She subsequently transitioned into the Oncology Pathology and Biomarker group, where she now explores novel spatial technologies to better understand tumor biology and heterogeneity.

14:00 - 14:25

Unlock Cell Population Discovery Using HALO Dimensional Analysis 

Dr. Ghislaine Lioux

Sr. Field Applications Scientist

Indica labs

Biography

Dr. Ghislaine Lioux is a Senior Field Application Scientist at Indica Labs. Ghislaine earned her PhD from the Spanish National Institute of Cardiovascular Research in Madrid as a Marie Curie Fellow, where she studied molecular mechanisms of heart development.

14:25 –14:50

Beyond the Basics: Customizing HALO Link Deployments

Kat Latimer, ME Biomedical Engineering

HALO Link Associate Product Manager

Indica Labs

Biography

Kat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression. In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience.

14:50 - 15:10

Coffee break and Networking

15:10 – 15:40

Digital Pathology for Clinical Research: How CellCarta Uses HALO to Accelerate Biomarker Development 

Alessandra Quarta, PhD

Senior Digital Pathology Scientist

CellCarta

Biography

 Alessandra Quarta earned a PhD in Medical Sciences from the University of Antwerp in 2020. For her research, she applied quantitative histology to study myeloid immune cell activation during neuroinflammatory processes. In 2021, Alessandra joined CellCarta, leveraging her expertise in digital image analysis to support biomarker development in clinical research. As a Senior Digital Pathology Scientist, her work centers on the end-to-end implementation of visual (pathologist‑driven) and automated (image‑analysis–driven) scoring algorithms for IHC and IF assays within a high‑quality–driven environment. She is also leading the COMET initiative within the Digital Pathology Solutions department, streamlining the analysis of COMET images and establishing a validated workflow to support the use of COMET assays in both R&D and clinical settings.

15:40 - 15:55

GCP, ADC, and Scalable AI: Pharma Services AI-driven Workflows 

Jeff Dzubay, PhD

Senior Director of Business Development - Pharma Services

Indica Labs

Biography

Jeff brings over two decades of experience in various technical and customer facing roles in imaging and image analysis in the biological sciences. This includes positions as Senior Scientist, Product Manager, and Director of Business Development. The past fourteen years he has been focused on digital pathology, computational pathology, and AI, primarily supporting pharma partners with their R&D efforts especially in the field of Immuno-oncology.  

15:55 – 16:00

Closing Remarks

Eileen Regan

VP, Life Science Applications, Global

Indica Labs